Want to see AU:OSL full AI Analyst Report?
Total Valuation
OncoSil Medical Ltd has a market cap or net worth of AU$29.91M. The enterprise value is AU$12.61M.
Market CapAU$29.91M
Enterprise ValueAU$12.61M
Share Statistics
OncoSil Medical Ltd has 36,703,940 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,703,940
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
OncoSil Medical Ltd’s return on equity (ROE) is -2.17 and return on invested capital (ROIC) is -218.71%.
Return on Equity (ROE)-2.17
Return on Assets (ROA)-1.05
Return on Invested Capital (ROIC)-218.71%
Return on Capital Employed (ROCE)-2.88
Revenue Per Employee280.83K
Profits Per Employee-1.81M
Employee Count6
Asset Turnover0.16
Inventory Turnover1.41K
Valuation Ratios
The current PE Ratio of OncoSil Medical Ltd is ―. OncoSil Medical Ltd’s PEG ratio is 0.02.
PE Ratio―
PS Ratio9.54
PB Ratio3.22
Price to FCF-1.54
Price to Operating Cash Flow-1.85
PEG Ratio0.02
Income Statement
In the last 12 months, OncoSil Medical Ltd had revenue of 1.68M and earned -10.86M in profits. Earnings per share was -0.48.
Revenue1.68M
Gross Profit-6.20M
Operating Income-14.42M
Pretax Income-14.26M
Net Income-10.86M
EBITDA-14.36M
Earnings Per Share (EPS)-0.48
Cash Flow
In the last 12 months, operating cash flow was -10.47M and capital expenditures -1.45K, giving a free cash flow of -10.47M billion.
Operating Cash Flow-10.47M
Free Cash Flow-10.47M
Free Cash Flow per Share-0.29
Dividends & Yields
OncoSil Medical Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.43
52-Week Price Change-48.40%
50-Day Moving Average0.95
200-Day Moving Average0.78
Relative Strength Index (RSI)44.17
Average Volume (3m)105.31K
Important Dates
OncoSil Medical Ltd upcoming earnings date is Mar 2, 2027, TBA (Confirmed).
Last Earnings DateAug 28, 2026
Next Earnings DateMar 2, 2027
Ex-Dividend Date―
Financial Position
OncoSil Medical Ltd as a current ratio of 1.77, with Debt / Equity ratio of 0.30%
Current Ratio1.77
Quick Ratio1.77
Debt to Market Cap<0.01
Net Debt to EBITDA0.45
Interest Coverage Ratio-858.22
Taxes
In the past 12 months, OncoSil Medical Ltd has paid -3.40M in taxes.
Income Tax-3.40M
Effective Tax Rate0.24
Enterprise Valuation
OncoSil Medical Ltd EV to EBITDA ratio is -0.67, with an EV/FCF ratio of -0.92.
EV to Sales5.71
EV to EBITDA-0.67
EV to Free Cash Flow-0.92
EV to Operating Cash Flow-0.92
Balance Sheet
OncoSil Medical Ltd has AU$6.48M in cash and marketable securities with AU$14.78K in debt, giving a net cash position of AU$6.46M billion.
Cash & Marketable SecuritiesAU$6.48M
Total DebtAU$14.78K
Net CashAU$6.46M
Net Cash Per ShareAU$0.18
Tangible Book Value Per ShareAU$0.22
Margins
Gross margin is -367.72%, with operating margin of -855.64%, and net profit margin of -644.53%.
Gross Margin-367.72%
Operating Margin-855.64%
Pretax Margin-846.55%
Net Profit Margin-644.53%
EBITDA Margin-852.10%
EBIT Margin-855.64%
Analyst Forecast
The average price target for OncoSil Medical Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast43.92%
EPS Growth Forecast65.23%